Effects of Three Dietary Strategies on Body Composition and Metabolic Health in Adults With Overweight or Obesity

NCT ID: NCT07314177

Last Updated: 2026-01-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

45 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-08

Study Completion Date

2025-06-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to compare the effects of three dietary interventions-a traditional Mediterranean diet, a Mediterranean low-carbohydrate diet, and a high-protein diet-on body composition, metabolic health markers, and metabolic syndrome remission in adults with overweight or obesity. A total of 45 participants will be randomly assigned to one of the three diets for 12 weeks, with regular follow-up by dietitians. Measurements will include weight, body fat, muscle mass, waist and hip circumference, blood pressure, and blood tests to assess glucose, cholesterol, inflammation, and other metabolic parameters. The findings will help determine whether one dietary pattern is more effective than others in improving short-term health outcomes in this population.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Detailed Description:

This randomized, controlled, parallel-group pilot clinical trial will evaluate the effects of three different hypocaloric dietary strategies on body composition, metabolic markers, and metabolic syndrome remission in adults with overweight or obesity.

Background and Rationale Overweight and obesity are highly prevalent in Europe and are associated with an increased risk of metabolic syndrome, cardiovascular disease, type 2 diabetes, and obesity-related cancers. Dietary interventions are a cornerstone in their management, but the optimal macronutrient composition for improving short-term metabolic outcomes remains unclear. This study investigates the comparative impact of a traditional Mediterranean diet, a Mediterranean low-carbohydrate diet, and a high-protein diet over a 12-week period.

Study Design A total of 45 participants aged 18-65 years with a body mass index (BMI) ≥25 kg/m² will be recruited through online advertisements and primary care referrals. After eligibility screening and informed consent, participants will be randomly allocated (1:1:1) to one of the three dietary intervention arms.

Intervention

All diets will be hypocaloric, aiming for a 20-25% reduction in individual energy requirements, and will differ in macronutrient distribution:

Mediterranean diet: 55% carbohydrates, 15% proteins, 30% fats.

Mediterranean low-carbohydrate diet: 40% carbohydrates, 25% proteins, 35% fats.

High-protein diet: 30% carbohydrates, 40% proteins, 30% fats.

Participants will be followed biweekly by qualified dietitians through in-person or phone consultations. They will receive personalized meal plans, nutritional education, and support materials to enhance adherence.

Assessments Anthropometric measures (BMI, fat mass, fat-free mass, waist and hip circumference) will be obtained at baseline and at 12 weeks using standardized protocols and validated equipment. Blood pressure will be measured with a calibrated automated device after a seated rest. Fasting blood samples will be collected in the morning for biochemical analyses, including glucose, HbA1c, insulin, lipid profile, uric acid, iron status, high-sensitivity C-reactive protein, fibrinogen, erythrocyte sedimentation rate, and liver enzymes.

Outcomes The primary outcome is the change in BMI after 12 weeks. Secondary outcomes include changes in body composition, metabolic and inflammatory biomarkers, and the proportion of participants meeting the International Diabetes Federation (IDF) criteria for metabolic syndrome at baseline and post-intervention.

Ethics and Dissemination The study protocol was approved by the Ethics Committee of Aragón (CEICA) (No. 13/2024) and will be conducted in accordance with the Declaration of Helsinki and current regulatory requirements. The findings will be disseminated through peer-reviewed publications and conference presentations.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Overweight (BMI > 25) Obesity &Amp; Overweight Metabolic Syndrome (MetS) Cardiometabolic Risk Factors

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm 1: Mediterranean Diet

Participants assigned to this arm will follow a traditional Mediterranean diet providing approximately 55% of total energy from carbohydrates, 15% from protein, and 30% from fats. The diet emphasizes whole grains, fruits, vegetables, legumes, nuts, olive oil as the primary fat source, moderate fish and poultry intake, and limited consumption of red and processed meats, sweets, and sugary beverages. The prescribed energy intake represents a 20-25% caloric deficit based on individual estimated requirements. Participants receive personalized meal plans, nutritional education, and biweekly follow-up by a registered dietitian.

Group Type EXPERIMENTAL

Mediterranean Diet

Intervention Type OTHER

A traditional Mediterranean diet providing approximately 55% of total energy from carbohydrates, 15% from protein, and 30% from fats. Emphasizes whole grains, vegetables, fruits, legumes, nuts, olive oil, moderate fish and poultry, and limited red meat, processed foods, and added sugars. Energy intake adjusted to achieve a 20-25% caloric deficit.

Arm 2: Mediterranean Low-Carbohydrate Diet

Participants assigned to this arm will follow a Mediterranean-style diet with a reduced carbohydrate content, providing approximately 40% of total energy from carbohydrates, 25% from protein, and 35% from fats. The diet retains the core principles of the Mediterranean pattern, emphasizing vegetables, fruits, legumes, nuts, fish, and olive oil, while limiting bread, pasta, rice, and other high-carbohydrate foods. Energy intake is individualized to achieve a 20-25% caloric deficit. Participants receive personalized meal plans, nutritional education, and biweekly follow-up by a registered dietitian.

Group Type EXPERIMENTAL

Mediterranean Low-Carbohydrate Diet

Intervention Type OTHER

A Mediterranean-style diet with reduced carbohydrate content (40% of total energy from carbohydrates, 25% from protein, and 35% from fats). Retains core Mediterranean foods while limiting bread, pasta, rice, and other high-carb foods. Energy intake adjusted to achieve a 20-25% caloric deficit.

Arm 3: High-Protein Diet

Participants assigned to this arm will follow a high-protein diet providing approximately 30% of total energy from carbohydrates, 40% from protein, and 30% from fats. Protein sources include lean meats, poultry, fish, eggs, and low-fat dairy products, combined with vegetables, nuts, and healthy fats such as olive oil. Refined carbohydrates and added sugars are limited. Energy intake is individualized to achieve a 20-25% caloric deficit. Participants receive personalized meal plans, nutritional education, and biweekly follow-up by a registered dietitian.

Group Type EXPERIMENTAL

High-Protein Diet

Intervention Type OTHER

A high-protein dietary pattern providing approximately 30% of total energy from carbohydrates, 40% from protein, and 30% from fats. Includes lean meats, poultry, fish, eggs, low-fat dairy, vegetables, nuts, and olive oil, with limited refined carbs and added sugars. Energy intake adjusted to achieve a 20-25% caloric deficit.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mediterranean Diet

A traditional Mediterranean diet providing approximately 55% of total energy from carbohydrates, 15% from protein, and 30% from fats. Emphasizes whole grains, vegetables, fruits, legumes, nuts, olive oil, moderate fish and poultry, and limited red meat, processed foods, and added sugars. Energy intake adjusted to achieve a 20-25% caloric deficit.

Intervention Type OTHER

Mediterranean Low-Carbohydrate Diet

A Mediterranean-style diet with reduced carbohydrate content (40% of total energy from carbohydrates, 25% from protein, and 35% from fats). Retains core Mediterranean foods while limiting bread, pasta, rice, and other high-carb foods. Energy intake adjusted to achieve a 20-25% caloric deficit.

Intervention Type OTHER

High-Protein Diet

A high-protein dietary pattern providing approximately 30% of total energy from carbohydrates, 40% from protein, and 30% from fats. Includes lean meats, poultry, fish, eggs, low-fat dairy, vegetables, nuts, and olive oil, with limited refined carbs and added sugars. Energy intake adjusted to achieve a 20-25% caloric deficit.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults aged 20-70 years
* Body mass index (BMI) ≥ 25 kg/m² (overweight or obesity)
* Stable body weight (± 2 kg) in the last 3 months prior to screening
* Willingness to follow one of the prescribed dietary interventions for 12 weeks
* Ability to attend scheduled follow-up visits and complete study assessments
* Provided written informed consent prior to study participation

Exclusion Criteria

* Diagnosis of type 1 diabetes, cardiovascular disease, cancer, chronic kidney disease, liver disease, or other serious chronic conditions that could interfere with the intervention
* Pregnancy or breastfeeding
* Current participation in another clinical trial
* History of bariatric surgery or weight-loss program within the past 6 months
* Use of medications known to affect body weight, metabolism, or appetite (e.g., glucocorticoids, weight-loss drugs, antipsychotics)
* Any food allergy or intolerance that would preclude adherence to the assigned diet
* Alcohol or substance abuse
* Any condition or circumstance that, in the opinion of the investigators, would make the participant unsuitable for the study
Minimum Eligible Age

20 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Consorcio Centro de Investigación Biomédica en Red (CIBER)

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Edificio SAI

Zaragoza, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CEICA-13/2024-PI24-171

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

PI24/171

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Body Weight and Vascular Function
NCT01675401 COMPLETED NA